Edwards Lifesciences Corp (EW)
86.46
-1.55
(-1.76%)
USD |
NYSE |
Apr 26, 16:00
86.46
0.00 (0.00%)
After-Hours: 20:00
Edwards Lifesciences Cash from Operations (TTM): 895.80M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 895.80M |
| September 30, 2023 | 1.042B |
| June 30, 2023 | 940.40M |
| March 31, 2023 | 1.239B |
| December 31, 2022 | 1.218B |
| September 30, 2022 | 1.309B |
| June 30, 2022 | 1.531B |
| March 31, 2022 | 1.725B |
| December 31, 2021 | 1.732B |
| September 30, 2021 | 1.758B |
| June 30, 2021 | 1.442B |
| March 31, 2021 | 1.148B |
| December 31, 2020 | 1.054B |
| September 30, 2020 | 1.057B |
| June 30, 2020 | 1.279B |
| March 31, 2020 | 1.388B |
| December 31, 2019 | 1.183B |
| September 30, 2019 | 1.073B |
| June 30, 2019 | 977.90M |
| March 31, 2019 | 776.90M |
| December 31, 2018 | 926.70M |
| September 30, 2018 | 997.70M |
| June 30, 2018 | 966.20M |
| March 31, 2018 | 1.024B |
| December 31, 2017 | 1.001B |
| Date | Value |
|---|---|
| September 30, 2017 | 837.90M |
| June 30, 2017 | 733.00M |
| March 31, 2017 | 725.60M |
| December 31, 2016 | 704.40M |
| September 30, 2016 | 607.10M |
| June 30, 2016 | 603.70M |
| March 31, 2016 | 583.50M |
| December 31, 2015 | 549.70M |
| September 30, 2015 | 539.10M |
| June 30, 2015 | 348.80M |
| March 31, 2015 | 956.70M |
| December 31, 2014 | 1.022B |
| September 30, 2014 | 1.040B |
| June 30, 2014 | 1.160B |
| March 31, 2014 | 510.50M |
| December 31, 2013 | 472.70M |
| September 30, 2013 | 476.10M |
| June 30, 2013 | 475.20M |
| March 31, 2013 | 493.90M |
| December 31, 2012 | 362.10M |
| September 30, 2012 | 340.80M |
| June 30, 2012 | 324.90M |
| March 31, 2012 | 262.60M |
| December 31, 2011 | 308.20M |
| September 30, 2011 | 308.80M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
895.80M
Minimum
Dec 2023
1.758B
Maximum
Sep 2021
1.263B
Average
1.218B
Median
Dec 2022
Cash from Operations (TTM) Benchmarks
| Stryker Corp | 3.711B |
| Boston Scientific Corp | 2.503B |
| Abbott Laboratories | 7.261B |
| Align Technology Inc | 785.78M |
| Steris PLC | 934.27M |